Travere Therapeutics, Inc.
US ˙ NasdaqGM ˙ US89422G1076

SecurityTVTX / Travere Therapeutics, Inc.
InstitutionTudor Investment Corp Et Al
ManagerPaul Tudor Jones
Latest Disclosed Ownership33,361 shares
Latest Disclosed Value $ 991,155
Tudor Investment Corp Et Al reports 46.35% decrease in ownership of TVTX / Travere Therapeutics, Inc.

On May 15, 2026 - Tudor Investment Corp Et Al filed a 13F-HR form disclosing ownership of 33,361 shares of Travere Therapeutics, Inc. (US:TVTX) valued at $991,155 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 62,186 shares of Travere Therapeutics, Inc.. This represents a change in shares of -46.35% during the quarter. The current value of the position is $1,507,917 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F Travere Therapeutics Inc - US Equity 89422G107 33,361 -28,825 -46.35 991 -58.29 0.0018
2026-02-17 2025-12-31 13F Travere Therapeutics Inc - US Equity 89422G107 62,186 -33,561 -35.05 2,376 3.85 0.0044
2025-12-09 2025-09-30 13F/A-1 Travere Therapeutics Inc - US Equity 89422G107 95,747 -105,761 -52.48 2,288 -23.27 0.0039
2025-11-14 2025-09-30 13F Travere TherapeutiCs InC - US Equity 89422G107 95,747 -105,761 2,288 0.0039
2025-08-14 2025-06-30 13F Travere Therapeutics Inc - US Equity 89422G107 201,508 38,130 23.34 2,982 1.88 0.0065
2025-05-15 2025-03-31 13F Travere Therapeutics Inc - US Equity 89422G107 163,378 120,165 278.08 2,928 289.23 0.0097
2025-02-14 2024-12-31 13F Travere Therapeutics Inc - US Equity 89422G107 43,213 5,069 13.29 753 41.09 0.0029
2024-11-14 2024-09-30 13F Travere Therapeutics Inc - US Equity 89422G107 38,144 861 2.31 534 74.18 0.0019
2024-08-14 2024-06-30 13F Travere Therapeutics Inc - US Equity 89422G107 37,283 -103 -0.28 306 6.25 0.0016
2024-05-15 2024-03-31 13F Travere Therapeutics Inc - US Equity 89422G107 37,386 37,386 288 0.0018
2024-02-14 2023-12-31 13F Travere Therapeutics Inc - US Equity 89422G107 0 -47,195 -100.00 0 -100.00
2023-11-15 2023-09-30 13F Travere Therapeutics Inc - US Equity 89422G107 47,195 -6,047 -11.36 422 -48.47 0.0042
2023-08-14 2023-06-30 13F Travere Therapeutics Inc - US Equity 89422G107 53,242 -13,528 -20.26 818 81,600.00 0.0098
2023-05-15 2023-03-31 13F Travere Therapeutics Inc - US Equity 89422G107 66,770 39,766 147.26 2 0.0232
2023-02-14 2022-12-31 13F Travere Therapeutics Inc - US Equity 89422G107 27,004 -4,908 -15.38 1 -100.00 0.0112
2022-11-14 2022-09-30 13F Travere Therapeutics Inc - US Equity 89422G107 31,912 31,912 786 0.0170
2022-08-15 2022-06-30 13F Travere Therapeutics Inc - US Equity 89422G107 0 -83,437 -100.00 0 -100.00
2022-05-16 2022-03-31 13F Travere Therapeutics Inc - US Equity 89422G107 83,437 20,928 33.48 2,150 10.82 0.0503
2022-02-14 2021-12-31 13F Travere Therapeutics Inc - US Equity 89422G107 62,509 5,757 10.14 1,940 40.99 0.0325
2021-11-17 2021-09-30 13F/A-1 Travere Therapeutics Equity 89422G107 56,752 -23,315 -29.12 1,376 17.81 0.0223
2021-11-15 2021-09-30 13F Travere Therapeutics Equity 89422G107 56,752 -23,315 1,376 0.0036
2021-08-16 2021-06-30 13F Travere Therapeutics Equity 89422G107 80,067 80,067 1,168 0.0221
2021-02-16 2020-12-31 13F Retrophin COMMON STOCK 761299106 0 -13,138 -100.00 0 -100.00
2020-11-16 2020-09-30 13F Retrophin COMMON STOCK 761299106 13,138 -55,482 -80.85 243 -82.66 0.0106
2020-08-14 2020-06-30 13F Retrophin COMMON STOCK 761299106 68,620 -11,504 -14.36 1,401 19.85 0.0694
2020-05-15 2020-03-31 13F Retrophin COMMON STOCK 761299106 80,124 -16,991 -17.50 1,169 -15.23 0.1047
2020-02-14 2019-12-31 13F Retrophin COMMON STOCK 761299106 97,115 -1,370 -1.39 1,379 20.86 0.0619
2019-11-14 2019-09-30 13F Retrophin COMMON STOCK 761299106 98,485 37,369 61.14 1,141 -7.08 0.0392
2019-08-14 2019-06-30 13F Retrophin COMMON STOCK 761299106 61,116 80 0.13 1,228 -11.08 0.0350
2019-05-15 2019-03-31 13F Retrophin COMMON STOCK 761299106 61,036 14,440 30.99 1,381 31.02 0.0571
2019-02-14 2018-12-31 13F Retrophin COMMON STOCK 761299106 46,596 58 0.12 1,054 -21.17 0.0208
2018-11-14 2018-09-30 13F Retrophin COMMON STOCK 761299106 46,538 -17,932 -27.81 1,337 -23.90 0.0336
2018-08-14 2018-06-30 13F Retrophin COMMON STOCK 761299106 64,470 32,999 104.86 1,757 149.57 0.0612
2018-05-15 2018-03-31 13F Retrophin COMMON STOCK 761299106 31,471 3,213 11.37 704 18.32 0.0228
2018-02-14 2017-12-31 13F Retrophin COMMON STOCK 761299106 28,258 -547 -1.90 595 -17.02 0.0151
2017-11-14 2017-09-30 13F Retrophin COMMON STOCK 761299106 28,805 -9,426 -24.66 717 -3.24 0.0183
2017-08-14 2017-06-30 13F Retrophin COMMON STOCK 761299106 38,231 -23,502 -38.07 741 -35.00 0.0226
2017-05-15 2017-03-31 13F Retrophin COMMON STOCK 761299106 61,733 10,067 19.48 1,140 16.56 0.0351
2017-02-14 2016-12-31 13F Retrophin COMMON STOCK 761299106 51,666 -14,547 -21.97 978 -34.01 0.0252
2016-11-14 2016-09-30 13F Retrophin COMMON STOCK 761299106 66,213 28,246 74.40 1,482 119.23 0.0347
2016-08-15 2016-06-30 13F Retrophin COMMON STOCK 761299106 37,967 13,802 57.12 676 104.85 0.0143
2016-05-16 2016-03-31 13F Retrophin COMMON STOCK 761299106 24,165 -2,500 -9.38 330 -35.80 0.0084
2016-02-16 2015-12-31 13F Retrophin COMMON STOCK 761299106 26,665 -14,143 -34.66 514 -37.85 0.0144
2015-11-16 2015-09-30 13F Retrophin COMMON STOCK 761299106 40,808 13,903 51.67 827 -7.29 0.0280
2015-08-14 2015-06-30 13F Retrophin COMMON STOCK 761299106 26,905 26,905 892 0.0261
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.